1 / 40

ACUTE ASTHMA IN CHILDREN AKUTE ASMA IN KINDERS

ACUTE ASTHMA IN CHILDREN AKUTE ASMA IN KINDERS. Prof Sharon Kling Dept Paediatrics & Child Health Stellenbosch University. What is acute asthma? Wat is akute asma?. Worsening of chronic asthma Worsening shortness of breath, cough, wheezing

juro
Download Presentation

ACUTE ASTHMA IN CHILDREN AKUTE ASMA IN KINDERS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. ACUTE ASTHMA IN CHILDRENAKUTE ASMA IN KINDERS Prof Sharon Kling Dept Paediatrics & Child Health Stellenbosch University

  2. What is acute asthma?Wat is akute asma? • Worsening of chronic asthma • Worsening shortness of breath, cough, wheezing • Which does not respond to usual reliever (bronchodilator) therapy • Verergering van chroniese asma • Verergerende kort-asemheid, hoes, fluit • Wat nie op gewone verligter (brongodilator) terapie respondeer nie

  3. Triggers of acute asthmaSnellers van akute asma • Viral respiratory tract infections - rhinovirus – the common cold • Environmental exposures • Environmental tobacco smoke • Allergens • Virale respiratoriese infeksies – verkoue - rinovirus • Omgewingsfaktore • Sigaretrook • Allergene

  4. Presentation / Presentasie • Cough / hoes • Wheezing / fluit • Increased work of breathing / Verhoogde werk van asemhaling • Anxiety / angs • Restlessness / rusteloosheid • Hypoxia / hipoksie

  5. Asthma mortality by country: Centers for Disease Control 2000 > 1.01 0.51 – 1.0 0 – 0.5 No standardized data available

  6. Definition / Definisie • Progressive respiratory failure due to acute asthmaProgressiewe respiratoriese versaking as gevolg van akute asma • Unresponsive to usual therapyWat nie op gewone terapie respondeer nie

  7. Pathophysiology of asthmaPatofisiologie van asma • Asthma is primarily an inflammatory disease / ‘n inflamma-toriese siekte Smooth muscle spasmGladdespierspasma Airway oedemaLugwegedeem Mucous pluggingMukusproppe

  8. Pathophysiology of acute asthma Patofisiologie van akute asma • Airway obstruction  air trapped in the lung with resultant hyperinflationLugweg obstruksie  lug word in long vas gevang met hiperinflasie • Ventilation / perfusion mismatch  hypoxaemia Ventilasie / perfusie wanbalans  hipoksemie • Increased work of breathing under hypoxic conditions  acidosisVerhoogde werk van asemhaling met hipoksie  asidose

  9. Acute Asthma: AssessmentAkute Asma: Evaluasie • History / Geskiedenis • Vital signs /Vitale tekens • Objective measurementsObjektiewe metings • Response to therapyRespons op behandeling

  10. Objective Evaluation Objektiewe Evaluasie • Respiratory rate / asemhalingsspoed • Retraction / retraksie • Ability to speak / vermoëomtepraat • Ability to feed / vermoëomtevoed • Peak flow / piekvloei • O2 saturation / O2saturasie

  11. Danger Signs in Acute AsthmaGevaartekens in Akute Asma • Rising pulse rate • Pulsusparadoxus • Agitation, restlessness or ↓ consciousnessSilent chest on auscultation • Chest pain • Cyanosis • Peak flow < 50% pred • Rising PaCO2 • Stygendepolsspoed • Pulsusparadoksus • Agitasie, rusteloos-heid, of ↓bewussyn • Stilborskas • Borskaspyn • Sianose • Piekvloei <50% voorsp • Stygende PaCO2

  12. Approach to acute asthmaBendering tot akute asma • Initiate therapy / begin terapie • Assessment / evaluering • Assess response to therapyEvalueer response op behandeling • Plan further therapy / managementBeplan verdere terapie / hantering

  13. Initiate Therapy:Begin Terapie: • OxygenSuurstof • Inhaled Beta-2 agonist Inhalasie Beta-2 agonis (salbutamol, fenoterol) • Oral steroids (prednisone)Orale steroïede (prednisoon)

  14. O2 4 L/min • ß2 agonist x2 20 min apart ACUTE ASTHMA ATTACK • ß2 agonist • MDI-spacer with face mask < 3 yrs; mouth piece > 3 yrs • 2-5 puffs; 1 puff every 10 secs • Nebulised 1ml in 3 ml normal saline

  15. O2 4 L/min • ß2 agonis x2 20 min uitmekaar AKUTE ASMA AANVAL • ß2 agonis • MDI-spacer met gesigmasker < 3 jaar; mondstuk > 3 jaar • 2-5 puffs; 1 puff elke 10 seks • Genebuliseer 1ml in 3 ml normal saline

  16. O2 4 L/min • ß-2 agonist x2 20 min apart ACUTE ASTHMA ATTACK EVALUATE RESPONSE NON- RESPONDER RESPONDER Peak flow > 80% pred/best < 80% pred/best Resp rate < 40 > 40 Retraction Absent Present Speech Normal Decreased Feeding Normal Decreased

  17. O2 4 L/min • ß-2 agonis x2 20 min uitmekaar AKUTE ASMA AANVAL EVALUEER RESPONS NIE- RESPONDEERDER RESPONDEERDER Piekvloei > 80% voorsp/beste < 80% voorsp/beste AH spoed < 40 > 40 Retraksie Afwesig Teenwoordig Spraak Normaal Verminder Voeding Normaal Verminder

  18. RESPONDER NON- RESPONDER • EVALUATE • Current therapy • Precipitating factors • Follow-up • INTENSIFY THERAPY • O2 • ß-2 agonist • Ipratropium bromide • Oral steroids (prednisone) • Hydration NON- RESPONDER EVALUATE AT DISCHARGE FOLLOW-UP WARD OR ICU

  19. RESPONDEERDER NIE-RESPONDEERDER • EVALUEER • Huidige terapie • Presipiterende faktore • Opvolg • INTENSIFISEER TERAPIE • O2 • ß2 agonis • Ipratropium bromied • Orale steroïede (prednisoon) • Hidrasie NIE-RESPONDEERDER EVALUEER MET ONTSLAG OPVOLG SAAL of ISE

  20. Acute asthma: first line therapyAkute asma: aanvanklike terapie • Oxygen / suurstof • Inhaled ß-2 agonists (short-acting)Inhalasie ß-2 agoniste (kortwerkend) • Corticosteroids (oral or IV)Kortikosteroïede (oraal of BA) • Fluid: do not overhydrate (50 ml/kg/24h)Vog: moet nie oorhidreer nie (50ml/kg/24uur)

  21. OxygenSuurstof

  22. Oxygen • Deliver high flow oxygen Hoëvloeisuurstof • Preferably via nasal catheterVerkieslikdmvnasalekateter

  23. Inhaled ß-2 agonistsInhalasie ß-2 agoniste

  24. Inhaled ß-2 agonistsInhalasie ß-2 agoniste • Examples / voorbeelde: • Salbutamol (Ventolin®, Venteze®, Asthavent®) • Formoterol (Berotec®)

  25. Method of AdministrationMetode van toediening • Nebuliser / nebuliseerder • MDI / spacer • more rapid onset / vinniger aankoms • fewer side-effects / minder newe-effekte • shorter time in hospital / korter hospitaal verblyf • Home-made spacers as effective as conventional spacerTuisgemaakte “spacers” net so effektief

  26. Nebuliser & MDI+spacer

  27. CorticosteroidsKortikosteroïede

  28. Corticosteroids: routeKortikosteroïede: roete • Oral preferable • As effective as IV • Less invasive • Less expensive • Dose: 1-2 mg/kg/day prednisone • Oraalverkieslik • Effektiefsoos BA • Minder indringend • Goedkoper • Dosering: 1-2 mg/kg/dag prednisoon

  29. Second Line TherapyTweedeLinieTerapie

  30. Anticholinergics / Anticholinergiesemiddels (Ipratropium bromide / bromied) • Magnesium sulphateMagnesium sulfaat • Adrenaline: subcutaneousAdrenalien: subkutaan

  31. AnticholinergicsAnticholinergieseMiddels • ß-2 agonist + ipratropium bromide (IB) given 4-6 hourlyß-2 agonis + ipratropiumbromied (IB) 4-6 uurliks • Examples / Voorbeelde IB: Atrovent®, Ipvent®

  32. Magnesium sulphate /sulfaat • For use in severe acute asthma • Causes relaxation of bronchial smooth muscle • Dose 40 mg/kg over 10 minutes • Gebruik in ergeakuteasma • Veroorsaakont-spanning van brongialegladdespier • Dosering 40 mg/kg oor 10 minute

  33. Adrenaline / Adrenalien • Only if no nebuliser or MDI available ORSlegs as geennebuliseerder of MDI beskikbaarnieOF • If patient moribund and unable to benefit from inhaled therapyAs pasiënt so siek is datinhalasieterapieniewerknie

  34. DO NOT USE MOET NIE GEBRUIK NIE • Sedatives • Physiotherapy • Routine antibiotics • Mucolytics • Antihistamines • Sedeermiddels • Fisioterapie • Roetineantibiotika • Mukolitika • Antihistamiene

  35. Danger Signs in Acute AsthmaGevaartekens in Akute Asma • Rising pulse rate • Pulsusparadoxus • Agitation, restlessness or ↓ consciousnessSilent chest on auscultation • Chest pain • Cyanosis • Peak flow < 50% pred • Rising PaCO2 • Stygendepolsspoed • Pulsusparadoksus • Agitasie, rusteloos-heid, of ↓bewussyn • Stilborskas • Borskaspyn • Sianose • Piekvloei <50% voorsp • Stygende PaCO2

  36. Indications for ICU admissionIndikasiesvir ISE toelating • Poor response to maximal therapy in ward • Hypoxaemia (PaO2 < 8kPa) despite O2 • PaCO2 > 4.5kPa • PEFR < 30% expected or best • Clinical signs of severe asthma • Swakrespons op maksimaleterapie in saal • Hipoksemie (PaO2 < 8kPa) tsv O2 • PaCO2 > 4.5kPa • PEFR < 30% voorspel of beste • Kliniesetekens van ergeasma

  37. Treatment in ICUBehandeling in ISE • Continuous inhalation of ß-2 agonist / anticholinergic combination • IV Aminophylline (theophylline) • IV ß-2 agonists (salbutamol) • Ventilation • Aanhoudendeinhalasieß-2 agonis / anticholinerge • BA aminofillien (teofillien) • BA ß-2 agoniste (salbutamol) • Ventilasie

  38. Aminophylline / Aminofillien • Narrow therapeutic indexSmalterapeutieseindeks • Side effects / newe-effekte • Cardiac arrhythmias / arritmeë • Hypotension / hipotensie • Convulsions / konvulsies • Use only in ICUGebruikslegs in ISE

  39. Summary / Opsomming

  40. Useful websites • National Asthma Education Programme (NAEP) www.asthma.co.za • Allergy Society of SA (ALLSA) www.allergysa.org • SA Thoracic Society (SATS) www.pulmonology.co.za

More Related